Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Spatial Neglect Following Stroke
NCT00955253Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Apr 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in hemispatial neglect, sponsored by Imperial College London. Started Apr 2010; status: completed.
02
Drugs
guanfacine
03
Conditions
hemispatial neglect
Beyond the preview
Go deeper on NCT00955253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955253.